Your browser doesn't support javascript.
loading
Efficacy and safety of gastric per-oral endoscopic myotomy (GPOEM) in lung transplant patients with refractory gastroparesis: a systematic review and meta-analysis.
Peppas, Spyros; Ahmad, Akram I; Altork, Nadera; Cho, Won Kyoo.
Afiliación
  • Peppas S; Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USA. peppas.spyros@gmail.com.
  • Ahmad AI; Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USA.
  • Altork N; Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USA.
  • Cho WK; Georgetown University School of Medicine, Washington, DC, USA.
Surg Endosc ; 37(9): 6695-6703, 2023 09.
Article en En | MEDLINE | ID: mdl-37479838
ABSTRACT

BACKGROUND:

Post-lung transplant gastroparesis is a frequent debilitating complication of lung transplant recipients, as it can increase the risk for gastro-esophageal reflux disease and subsequent graft dysfunction. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of GPOEM in lung transplant patients with refractory gastroparesis.

METHODS:

The present systematic review and meta-analysis wer performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. We selected studies that analyzed the gastroparesis cardinal symptom index (GCSI) before and after the procedure to verify the efficacy of GPOEM. Random-effects model was used and the analysis was performed with STATA 17.

RESULTS:

Four observational studies (one conference abstract) with 104 patients were included in the meta-analysis. Prior treatments for gastroparesis included prokinetic agents and botulinum toxin in 78% (78/104) and 66.7% (66/99), respectively. Pooled estimate for clinical efficacy of GPOEM was 83% (95% CI 76%-90%). The pooled mean reduction in GCSI following the procedure was - 2.01 (- 2.35, - 1.65, p = 0.014). Three studies reported statistically significant improvement of gastro-esophageal retention or emptying in the post-GPOEM period. 30-day post-operative complications included minor or major bleeding (11.6%), severe reflux (1.2%), and pyloric stenosis (1.2%) requiring re-intervention. 90-day all-cause mortality was 2.6% with one patient dying from severe allograft rejection.

CONCLUSION:

Our study showed that GPOEM is an effective and safe strategy for lung transplant patients with refractory gastroparesis and should be considered as a therapeutic strategy in this population. Larger multicenter trials are needed in the future to further evaluate the effect of GPOEM on allograft function and rates of rejection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases Asunto principal: Trasplante de Pulmón / Gastroparesia / Estenosis Hipertrófica del Piloro / Miotomía Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Surg Endosc Asunto de la revista: DIAGNOSTICO POR IMAGEM / GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases Asunto principal: Trasplante de Pulmón / Gastroparesia / Estenosis Hipertrófica del Piloro / Miotomía Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Surg Endosc Asunto de la revista: DIAGNOSTICO POR IMAGEM / GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...